Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design
Open Access
- 12 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (13), 7066-7080
- https://doi.org/10.1021/acs.jmedchem.0c00373
Abstract
The Mg2+-dependent Mycobacterium tuberculosis salicylate synthase (MbtI) is a key enzyme involved in the biosynthesis of siderophores. Because iron is essential for the survival and pathogenicity of the microorganism, this protein constitutes an attractive target for antitubercular therapy, also considering the absence of homologous enzymes in mammals. An extension of the structure–activity relationships of our furan-based candidates allowed us to disclose the most potent competitive inhibitor known to date (10, Ki = 4 μM), which also proved effective on mycobacterial cultures. By structural studies, we characterized its unexpected Mg2+-independent binding mode. We also investigated the role of the Mg2+ cofactor in catalysis, analyzing the first crystal structure of the MbtI–Mg2+–salicylate ternary complex. Overall, these results pave the way for the development of novel antituberculars through the rational design of improved MbtI inhibitors.Funding Information
- Universit? degli Studi di Milano
- Universit? degli Studi di Pavia
- Ministero dell?Istruzione, dell?Universit? e della Ricerca
- Centre National de la Recherche Scientifique
- Institut Pasteur
This publication has 38 references indexed in Scilit:
- Linking Crystallographic Model and Data QualityScience, 2012
- Data processing and analysis with theautoPROCtoolboxActa Crystallographica Section D-Biological Crystallography, 2011
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D-Biological Crystallography, 2011
- Inhibitors of the Salicylate Synthase (MbtI) from Mycobacterium tuberculosis Discovered by High‐Throughput ScreeningChemMedChem, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D-Biological Crystallography, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D-Biological Crystallography, 2009
- Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisitionProceedings of the National Academy of Sciences, 2009
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- Improved protein–ligand docking using GOLDProteins-Structure Function and Bioinformatics, 2003